Sonnet biotherapeutics to participate in the virtual investor closing bell series

Princeton, n.j., sept. 04, 2024 (globe newswire) -- sonnet biotherapeutics holdings, inc. (the “company” or “sonnet”) (nasdaq: sonn), a clinical-stage company developing targeted immunotherapeutic drugs, today announced that it will participate in the virtual investor closing bell series on monday, september 9, 2024, at 4:00 pm et.

SONN Ratings Summary

SONN Quant Ranking